Litigation Details for Premera Blue Cross v. Takeda Pharmaceutical Company Limited (D. Mass. 2023)
✉ Email this page to a colleague
Premera Blue Cross v. Takeda Pharmaceutical Company Limited (D. Mass. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-11-30 |
| Court | District Court, D. Massachusetts | Date Terminated | |
| Cause | 28:1332 Diversity-Contract Dispute | Assigned To | Myong J. Joun |
| Jury Demand | Plaintiff | Referred To | Mary Page Kelley |
| Patents | 6,414,016; 6,583,174; 6,982,283; 7,064,148; 7,417,067; 7,795,312; 8,026,393; 8,071,613; 8,088,934; 8,097,649; 8,097,653; 8,114,890; 8,338,639; 8,389,542; 8,748,481; 8,779,187 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Premera Blue Cross v. Takeda Pharmaceutical Company Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Premera Blue Cross v. Takeda Pharmaceutical Company Limited (D. Mass. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-11-30 | 1 | Complaint | IV (“the ‘312 patent”) (09/17/2024) 6,414,016 …312 patent, the ‘653 patent, the ‘542 patent, the ‘393 patent, and the ‘639 patent (five…infringement of the ‘653 patent, the ‘542 patent, the ‘393 patent, and the ‘639 patent (four of the seven…Takeda had to sign off on any patent prosecutions, patent strategy, and patent infringement lawsuits. Takeda…seven patents underlying the Par litigation, as well as the ‘283 patent and the ‘481 patent. Sucampo | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
